Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 7, Pages 6578
Publisher
MDPI AG
Online
2023-04-03
DOI
10.3390/ijms24076578
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis
- (2022) David Jayne et al. ANNALS OF THE RHEUMATIC DISEASES
- Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials
- (2022) Edward M Vital et al. ANNALS OF THE RHEUMATIC DISEASES
- Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria
- (2022) Ronald van Vollenhoven et al. Lupus Science & Medicine
- Cytokine Storm—Definition, Causes, and Implications
- (2022) Dominik Jarczak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
- (2022) Andreas Mackensen et al. NATURE MEDICINE
- The Double Game Played by Th17 Cells in Infection: Host Defense and Immunopathology
- (2022) Marino Paroli et al. Pathogens
- T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update
- (2021) Ping-Min Chen et al. Current Rheumatology Reports
- Voclosporin: First Approval
- (2021) Young-A Heo DRUGS
- Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus
- (2021) Johannes Hartl et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
- (2021) Brad H Rovin et al. LANCET
- Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus
- (2021) Richard Furie et al. LUPUS
- A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis.
- (2021) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
- (2021) Dimitrios Mougiakakos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential for Antigen-Specific Tolerizing Immunotherapy in Systematic Lupus Erythematosus
- (2021) Sean Robinson et al. Frontiers in Immunology
- Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
- (2021) Celline C Almeida-Brasil et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies
- (2021) Manuel Francisco Ugarte-Gil et al. Lupus Science & Medicine
- Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
- (2021) P.J. Hayden et al. ANNALS OF ONCOLOGY
- The role of socioeconomic status in the susceptibility to develop systemic lupus erythematosus in Mexican patients
- (2020) Norma Alicia Salgado-Galicia et al. CLINICAL RHEUMATOLOGY
- The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections
- (2020) Eri Katsuyama et al. Cell Reports
- Plasmacytoid Dendritic Cells and Type I Interferon Promote Extrafollicular B Cell Responses to Extracellular Self-DNA
- (2020) Chetna Soni et al. IMMUNITY
- Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial
- (2020) Hermine I Brunner et al. ANNALS OF THE RHEUMATIC DISEASES
- Lupus-like autoimmunity and increased interferon response in patients with STAT3-deficient hyper-IgE syndrome
- (2020) Rishi R. Goel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cells
- (2020) Cesar A. Corzo et al. Science Signaling
- Antinuclear Antibodies With a Homogeneous and Speckled Immunofluorescence Pattern Are Associated With Lack of Cancer While Those With a Nucleolar Pattern With the Presence of Cancer
- (2020) Amandine Gauderon et al. Frontiers in Medicine
- Update οn the diagnosis and management of systemic lupus erythematosus
- (2020) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- IFN Regulatory Factor 3 in Health and Disease
- (2020) Thomas M. Petro JOURNAL OF IMMUNOLOGY
- Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials
- (2020) Yoshiya Tanaka et al. Modern Rheumatology
- New insights into the role of antinuclear antibodies in systemic lupus erythematosus
- (2020) David S. Pisetsky et al. Nature Reviews Rheumatology
- Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus
- (2020) Lennard Ostendorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
- (2020) Richard Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Type II anti‐CD20 Antibody Obinutuzumab (GA101) is More Effective than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus Model
- (2020) Anthony D. Marinov et al. Arthritis & Rheumatology
- Hematopoietic Stem Cell Transplantation for Autoimmune Disease
- (2020) Tobias Alexander et al. Annual Review of Medicine
- Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis
- (2019) Murray B Urowitz et al. ANNALS OF THE RHEUMATIC DISEASES
- To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps
- (2019) Sebastian Boeltz et al. CELL DEATH AND DIFFERENTIATION
- Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus
- (2019) Rita Kansal et al. Science Translational Medicine
- Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus
- (2019) Richard Furie et al. JOURNAL OF CLINICAL INVESTIGATION
- Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus
- (2019) Saifur Rahman et al. ANNALS OF THE RHEUMATIC DISEASES
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
- (2019) Rafael F. Duarte et al. BONE MARROW TRANSPLANTATION
- Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus
- (2019) Lina Odqvist et al. ANNALS OF THE RHEUMATIC DISEASES
- Design and Evaluation of Highly Selective Human Immunoproteasome Inhibitors Reveal a Compensatory Process That Preserves Immune Cell Viability
- (2019) Ena Ladi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel paradigms in systemic lupus erythematosus
- (2019) Thomas Dörner et al. LANCET
- Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension
- (2019) Ronald F van Vollenhoven et al. RHEUMATOLOGY
- Mesenchymal stem cell therapy induces FLT3L and CD1c+ dendritic cells in systemic lupus erythematosus patients
- (2019) Xinran Yuan et al. Nature Communications
- Interferon-Stimulated Genes: What Do They All Do?
- (2019) John W. Schoggins Annual Review of Virology
- Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA
- (2019) Yann Becker et al. Frontiers in Immunology
- Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties
- (2019) Raffaella Greco et al. Frontiers in Immunology
- 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
- (2019) Martin Aringer et al. ANNALS OF THE RHEUMATIC DISEASES
- BAFF inhibition in SLE-Is tolerance restored?
- (2019) Shaun W Jackson et al. IMMUNOLOGICAL REVIEWS
- Next-generation regulatory T cell therapy
- (2019) Leonardo M. R. Ferreira et al. NATURE REVIEWS DRUG DISCOVERY
- Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
- (2019) I-Tsu Chyuan et al. Cells
- Diagnostic performance of aPS/PT antibodies in neuropsychiatric lupus and cardiovascular complications of SLE
- (2019) Giuseppe A. Ramirez et al. AUTOIMMUNITY
- Interferon target-gene expression and epigenomic signatures in health and disease
- (2019) Franck J. Barrat et al. NATURE IMMUNOLOGY
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: effect of conditioning regimen on outcome
- (2018) Richard K. Burt et al. BONE MARROW TRANSPLANTATION
- New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies
- (2018) Saskia Meyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Epidemiology of systemic lupus erythematosus
- (2018) George Stojan et al. CURRENT OPINION IN RHEUMATOLOGY
- Development of a Target cell-Biologics-Effector cell (TBE) complex-based cell killing model to characterize target cell depletion by T cell redirecting bispecific agents
- (2018) Xiling Jiang et al. mAbs
- Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosus
- (2018) Tomonori Ishii et al. Modern Rheumatology
- Apoptotic cell–induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans
- (2018) Rahul Shinde et al. NATURE IMMUNOLOGY
- The role of neutrophil extracellular traps in rheumatic diseases
- (2018) Falko Apel et al. Nature Reviews Rheumatology
- Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination
- (2018) Deborah L. Burnett et al. SCIENCE
- Tregs in SLE: an Update
- (2018) Antonio La Cava Current Rheumatology Reports
- Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus
- (2018) Richard A. Furie et al. Arthritis & Rheumatology
- Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene
- (2018) Monica Casucci et al. Frontiers in Immunology
- Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis
- (2018) Liliana Michelle Gomez Mendez et al. Clinical Journal of the American Society of Nephrology
- Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus
- (2018) Kei Sakata et al. Frontiers in Immunology
- Novel Sjögren's autoantibodies found in fibromyalgia patients with sicca and/or xerostomia
- (2018) Eliana Applbaum et al. AUTOIMMUNITY REVIEWS
- The Jakinibs in systemic lupus erythematosus: progress and prospects
- (2018) Chi Chiu Mok EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Mortality in systemic lupus erythematosus: causes, predictors and interventions
- (2018) Vanessa Ocampo-Piraquive et al. Expert Review of Clinical Immunology
- Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus
- (2018) Scott A. Jenks et al. IMMUNITY
- Systemic lupus erythematosus: Diagnosis and clinical management
- (2018) Andrea Fava et al. JOURNAL OF AUTOIMMUNITY
- A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis
- (2018) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- Haematopoietic stem cell transplantation for autoimmune diseases
- (2017) Joost F. Swart et al. Nature Reviews Rheumatology
- The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies
- (2017) Frances Rees et al. RHEUMATOLOGY
- Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus
- (2017) Denis Comte et al. Arthritis & Rheumatology
- Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
- (2017) Richard Furie et al. Arthritis & Rheumatology
- Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
- (2017) William Stohl et al. Arthritis & Rheumatology
- Interferon-Lambda: A Potent Regulator of Intestinal Viral Infections
- (2017) Sanghyun Lee et al. Frontiers in Immunology
- A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
- (2016) Ronald van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity
- (2016) Vanja Sisirak et al. CELL
- Progress and Paradigms in Multiple Myeloma
- (2016) Kenneth C. Anderson CLINICAL CANCER RESEARCH
- A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus
- (2016) Madhvi Menon et al. IMMUNITY
- Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus
- (2016) Simone Caielli et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis
- (2016) Y H Lee et al. LUPUS
- Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease
- (2016) Christian Lood et al. NATURE MEDICINE
- Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
- (2016) C. T. Ellebrecht et al. SCIENCE
- A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients
- (2016) Patricia López et al. Scientific Reports
- Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
- (2015) Kate Franklyn et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment
- (2015) Agneta Zickert et al. BMC IMMUNOLOGY
- Advances in lupus genetics
- (2015) Timothy B. Niewold CURRENT OPINION IN RHEUMATOLOGY
- CD4+CXCR3+ T cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus
- (2015) Marc Clement et al. JOURNAL OF AUTOIMMUNITY
- Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity
- (2015) A Midgley et al. LUPUS
- T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
- (2015) Eoin F. McKinney et al. NATURE
- The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity
- (2015) Buvana Ravishankar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease
- (2015) Jessica L. Grieves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research
- (2015) Jamal Mikdashi et al. ARTHRITIS RESEARCH & THERAPY
- Association of mtDNA M/N haplogroups with systemic lupus erythematosus: a case-control study of Han Chinese women
- (2015) Youzhou Tang et al. Scientific Reports
- The W620 Polymorphism in PTPN22 Disrupts Its Interaction With Peptidylarginine Deiminase Type 4 and Enhances Citrullination and NETosis
- (2015) Hui-Hsin Chang et al. Arthritis & Rheumatology
- Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lprmice
- (2014) Jason S Knight et al. ANNALS OF THE RHEUMATIC DISEASES
- Systemic lupus erythematosus complicated with thymoma and pure red cell aplasia (PCRA). CR of both complications following thymectomy and allogeneic haematopoietic SCT (HSCT), but persistence of antinuclear antibodies (ANA)
- (2014) A M Marmont et al. BONE MARROW TRANSPLANTATION
- Experimental evidence that mutated-self peptides derived from mitochondrial DNA somatic mutations have the potential to trigger autoimmunity
- (2014) Lina Chen et al. HUMAN IMMUNOLOGY
- Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus
- (2014) Vanja Sisirak et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mitochondrial DNA damage is associated with damage accrual and disease duration in patients with Systemic Lupus Erythematosus
- (2014) L López-López et al. LUPUS
- Cell Distance Mapping Identifies Functional T Follicular Helper Cells in Inflamed Human Renal Tissue
- (2014) V. M. Liarski et al. Science Translational Medicine
- The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
- (2014) M. Hudecek et al. Cancer Immunology Research
- TLR9 independent interferon α production by neutrophils on NETosis in response to circulating chromatin, a key lupus autoantigen
- (2013) Dennis Lindau et al. ANNALS OF THE RHEUMATIC DISEASES
- Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials
- (2013) Michelle A. Petri et al. ARTHRITIS AND RHEUMATISM
- Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study
- (2013) Eduardo F. Mysler et al. ARTHRITIS AND RHEUMATISM
- Neutrophil-Mediated IFN Activation in the Bone Marrow Alters B Cell Development in Human and Murine Systemic Lupus Erythematosus
- (2013) A. Palanichamy et al. JOURNAL OF IMMUNOLOGY
- Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as Susceptibility Loci for Systemic Lupus Erythematosus in a Large-Scale Multiracial Replication Study
- (2012) Christopher J. Lessard et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Foxp3+Helios+regulatory T cells are expanded in active systemic lupus erythematosus
- (2012) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- Neutrophil Extracellular Trap-Associated Protein Activation of the NLRP3 Inflammasome Is Enhanced in Lupus Macrophages
- (2012) J. M. Kahlenberg et al. JOURNAL OF IMMUNOLOGY
- Endogenous antigen tunes the responsiveness of naive B cells but not T cells
- (2012) Julie Zikherman et al. NATURE
- Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase
- (2012) B. Ravishankar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- The Systemic Lupus Erythematosus Responder Index (SRI); A new SLE disease activity assessment
- (2011) K.M.A.C. Luijten et al. AUTOIMMUNITY REVIEWS
- Generation of Human Regulatory T Cells by TCR Stimulation in the Presence of TGF- and Their Involvement in the Pathogenesis of Systemic Lupus Erythematosus
- (2011) X. Li et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus
- (2011) Sulaiman M Al-Mayouf et al. NATURE GENETICS
- Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase
- (2011) C. O. Jacob et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus
- (2011) R. Lande et al. Science Translational Medicine
- Antimalarial treatment may have a time-dependent effect on lupus survival: Data from a multinational Latin American inception cohort
- (2010) Samuel K. Shinjo et al. ARTHRITIS AND RHEUMATISM
- Oxidative stress in systemic lupus erythematosus: Relationship to Th1 cytokine and disease activity
- (2010) Dilip Shah et al. IMMUNOLOGY LETTERS
- A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs
- (2010) M. F. Denny et al. JOURNAL OF IMMUNOLOGY
- Circulating mitochondrial DAMPs cause inflammatory responses to injury
- (2010) Qin Zhang et al. NATURE
- Reviewing the evidence for mycophenolate mofetil as a new teratogen: Case report and review of the literature
- (2009) Marlene T. Anderka et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome
- (2009) J. Pijpe et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion
- (2009) B. Jahrsdorfer et al. BLOOD
- The mtDNA nt7778 G/T polymorphism affects autoimmune diseases and reproductive performance in the mouse
- (2009) Xinhua Yu et al. HUMAN MOLECULAR GENETICS
- Mitochondrial DNA polymorphisms are associated with susceptibility and phenotype of systemic lupus erythematosus
- (2009) A Jönsen et al. LUPUS
- Cyclophosphamide and cancer: golden anniversary
- (2009) Ashkan Emadi et al. Nature Reviews Clinical Oncology
- Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation
- (2008) Y K O Teng et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
- (2008) G Ruiz-Irastorza et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus
- (2008) Tamara Vyshkina et al. CLINICAL IMMUNOLOGY
- Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)
- (2008) M. Bonelli et al. INTERNATIONAL IMMUNOLOGY
- Interferon Alpha-Induced Lupus
- (2008) Timothy B. Niewold JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci
- (2008) John B Harley et al. NATURE GENETICS
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- Association of Systemic Lupus Erythematosus withC8orf13–BLKandITGAM–ITGAX
- (2008) Geoffrey Hom et al. NEW ENGLAND JOURNAL OF MEDICINE
- BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact
- (2008) J. L. Scholz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis
- (2007) Nicoletta Fiore et al. MOLECULAR IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started